Not applicableUnknownNCT03517332What this trial is testingCirculating Tumor DNA Exposure in Peripheral BloodWho this might be right forColorectal CancerPancreatic AdenocarcinomaGastric Cancer+8 more Quantgene Inc. 10,000
Early research (Phase 1)Looking for participantsNCT06999187What this trial is testingDR-0202 in Patients With Locally Advanced or Metastatic, Relapsed or Refractory CarcinomasWho this might be right forTriple Negative Breast CancerHER2-negative Breast CancerNon Small Cell Lung Cancer+9 more Dren Bio 96
Testing effectiveness (Phase 2)Looking for participantsNCT07285044What this trial is testingThe Cancer Connected Access and Remote Expertise Beyond Walls Program to Provide In-Home Cancer Treatment and Improve Treatment Satisfaction in Cancer Patients Living in the Florida Panhandle and Surrounding AreasWho this might be right forAmyloidosisBasal Cell CarcinomaBiliary Tract Carcinoma+26 more Mayo Clinic 27
Testing effectiveness (Phase 2)WithdrawnNCT03240393What this trial is testingStudy of Oral cMET Inhibitor INC280 in Chinese Patients With EGFR Wild-type Advanced Non-small Cell Lung Cancer (NSCLC)Who this might be right forCarcinomaNon-Small-Cell Lung Cancer Novartis Pharmaceuticals
Testing effectiveness (Phase 2)Active Not RecruitingNCT03157128What this trial is testingSelpercatinib (LOXO-292) in Participants With Advanced Solid Tumors, RET Fusion-Positive Solid Tumors, and Medullary Thyroid Cancer (LIBRETTO-001)Who this might be right forNon-Small Cell Lung CancerMedullary Thyroid CancerColon Cancer+1 more Eli Lilly and Company 857
Early research (Phase 1)Ended earlyNCT05061537What this trial is testingStudy of PF-07263689 in Participants With Selected Advanced Solid TumorsWho this might be right forRenal Cell CancerMelanomaNon-Small-Cell Lung Cancer+7 more Pfizer 13
Testing effectiveness (Phase 2)Active Not RecruitingNCT06099782What this trial is testingParticipant Reported Preference for Subcutaneous Pembrolizumab Coformulated With Berahyaluronidase Alfa (MK-3475A) Over Intravenous Pembrolizumab (MK-3475) Formulation in Multiple Tumor Types (MK-3475A-F11)Who this might be right forNon-Small Cell Lung CancerRenal Cell CarcinomaMelanoma Merck Sharp & Dohme LLC 147
Large-scale testing (Phase 3)Not Yet RecruitingNCT07169903What this trial is testingSegmentectomy vs Lobectomy for 2 - 3cm IASLC Grade 1-2 Lung Adenocarcinoma: A Multi-center RCTWho this might be right forLung Adenocarcinoma Shanghai Pulmonary Hospital, Shanghai, China 587
Early research (Phase 1)Not Yet RecruitingNCT07675876What this trial is testingInhaled Cromolyn Sodium in Patients With Locally Advanced Lung CancerWho this might be right forLocally Advanced Non-Small Cell Lung CancerLung Adenocarcinoma Carcinex Inc 10
Early research (Phase 1)Active Not RecruitingNCT04514497What this trial is testingTesting the Addition of an Anti-cancer Drug, BAY 1895344, to Usual Chemotherapy for Advanced Stage Solid Tumors, With a Specific Focus on Patients With Small Cell Lung Cancer, Poorly Differentiated Neuroendocrine Cancer, and Pancreatic CancerWho this might be right forMetastatic Lung Small Cell CarcinomaMetastatic Malignant Solid NeoplasmMetastatic Neuroendocrine Carcinoma+9 more National Cancer Institute (NCI) 29
Early research (Phase 1)Active Not RecruitingNCT02988960What this trial is testingABBV-927 and ABBV-181, an Immunotherapy, in Participants With Advanced Solid TumorsWho this might be right forAdvanced Solid Tumors Cancer AbbVie 163
Not applicableUnknownNCT06363123What this trial is testingPlasma Metabolic Biomarkers for Multi-Cancer DiagnosisWho this might be right forLung CancerBreast CancerColorectal Cancer+10 more Beijing Friendship Hospital 2,700
Early research (Phase 1)Study completedNCT00010023What this trial is testingCapecitabine Combined With Cisplatin in Treating Patients With Locally Advanced or Metastatic Solid TumorsWho this might be right forCancer NYU Langone Health
Post-approval studies (Phase 4)UnknownNCT04401059What this trial is testingSynergistic Effect of Elemene Plus TKIs Compared With TKIs in EGFR-mutated Advanced NSCLC：Prospective StudyWho this might be right forCarcinomaNon-Small-Cell Lung CancerAdenocarcinoma Tian Xie 744
Large-scale testing (Phase 3)Active Not RecruitingNCT05078047What this trial is testingStudy Comparing the Standard Administration of IO Versus the Same IO Administered Each 3 Months in Patients in Response After 6 Months of Standard IOWho this might be right forLung Cancer MetastaticRenal Cell CarcinomaHead and Neck Cancer+12 more UNICANCER 646
Testing effectiveness (Phase 2)Study completedNCT03267316What this trial is testingA First-in-Human Study of CAN04 in Patients With Solid Malignant TumorsWho this might be right forNon Small Cell Lung CancerPancreatic Ductal AdenocarcinomaTriple Negative Breast Cancer+1 more Cantargia AB 167
Testing effectiveness (Phase 2)Temporarily pausedNCT05337735What this trial is testingA Phase II Clinical Trial to Evaluate Safety and Efficacy of XmAb20717 in Advanced Rare CancersWho this might be right forMicrosatellite High CancersPeritoneal MesotheliomaExtrapulmonary High Grade+5 more M.D. Anderson Cancer Center 140
Testing effectiveness (Phase 2)Looking for participantsNCT05985655What this trial is testingStudy to Assess GTAEXS617 in Participants With Advanced Solid TumorsWho this might be right forHead and Neck Squamous Cell Carcinoma (HNSCC)Pancreatic AdenocarcinomaNon-small Cell Lung Cancer (NSCLC)+3 more Exscientia AI Ltd., a wholly owned subsidiary of Recursion Pharmaceuticals, Inc. 230
Not applicableUnknownNCT04692935What this trial is testingComparative Genomic Profiling of Lung Adenocarcinoma in Asians and Caucasians: A Propensity Matched AnalysisWho this might be right forAdenocarcinoma of Lung Jun Wang 450
Post-approval studies (Phase 4)Study completedNCT02151149What this trial is testingSafety and Efficacy Study of Abraxane in Combination With Carboplatin to Treat Advanced NSCL Cancer in the ElderlyWho this might be right forNon-Small Cell Lung CancerCarcinomaSquamous Cell Carcinoma+3 more Celgene 143